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ABSTRACT
Side-effects of iron supplementation lead to poor compliance. A weekly-dose schedule of iron
supplementation rather than a daily-dose regimen has been suggested to produce fewer side-effects,
thereby achieving a higher compliance. This study compared side-effects of iron supplementation
and their impact on compliance among pregnant women in Bangladesh. These women were assigned
to receive either weekly doses of 2x60 mg iron (one tablet each Friday morning and evening) or a
daily dose of 1x60 mg iron. Fifty antenatal care centres were randomly assigned to prescribe either a
weekly- or a daily-supplementation regimen (86 women in each group). Side-effects were assessed
by recall after one month of supplementation and used for predicting compliance in the second and
third months of supplementation. Compliance was monitored using a pill bottle equipped with an
electronic counting device that recorded date and time whenever the pill bottle was opened. Of five
gastrointestinal side-effects (heartburn, nausea, vomiting, diarrhoea, or constipation) assessed, vomiting
occurred more frequently in the weekly group (21%) than in the daily group (11%, p<0.05). Compliance
(ratio between observed and recommended tablet intake) was significantly higher in the weekly-
supplementation regimen (93%) than in the daily-supplementation regimen (61%, p<0.05). Overall,
gastrointestinal side-effects were not significantly associated with compliance. However, the presence
of nausea and/or vomiting reduced compliance in both the regimens—but only among women from
the lower socioeconomic group. In conclusion, weekly supplementation of iron in pregnancy  had a
higher compliance compared to daily supplementation of iron despite a higher frequency of side-
effects. The findings support the view that gastrointestinal side-effects generally have a limited
influence on compliance, at least in the dose ranges studied. Efforts to further reduce side-effects of
iron supplementation may not be a successful strategy for improving  compliance and effectiveness
of antenatal iron supplementation.
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INTRODUCTION
Gastrointestinal side-effects of iron supplementation
cause poor compliance, resulting in ineffective
supplementation programmes. It has been suggested that
a weekly-supplementation schedule is likely to produce
fewer side-effects and consequently increase compliance
(1). Great variation in the occurrence of reported side-
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effects in iron-supplementation trials even with similar
doses of iron has been observed. Appropriate counselling
on what to expect in terms of side-effects may modify
the perception of side-effects or counteract their negative
effect on compliance (2).
This study was nested into an iron-supplementation
trial among pregnant women in Bangladesh, where the
response in haemoglobin concentration was compared
between daily- and weekly-iron supplementation and in
this process differentiating between biologically and
behaviourally-induced differences, such as compliance
(3). This study  aimed at comparing side-effects of iron
supplementation, compliance, and impact of side-effects
on compliance among pregnant women assigned to either
weekly doses of 2x60 mg iron or a daily dose of 1x60
mg iron.
MATERIALS AND METHODS
The study was conducted among pregnant women in
rural areas of Mymensingh district of northern
Bangladesh. This flat agricultural area has a high
population density, low literacy, and high rates of
malnutrition. The Bangladesh Rural Advancement
Committee (BRAC), a large national private
development organization, supports the antenatal care
activities of the government, including provision of iron
supplementation to pregnant women, through its
community-based antenatal care centres (ANCCs). Each
ANCC covers a population of about 1,000, is managed
by a female voluntary health worker, and operates on a
monthly schedule.
Fifty ANCCs were randomly assigned to prescribe
either one iron supplement daily or two supplements each
Friday (one in the morning and one in the afternoon) to
participating women. Each supplement contained the
equivalent of 60 mg iron and 250 µg folic acid.
Based on formative research, a uniform message was
developed and given to pregnant mothers at the start of
the supplementation regarding the rationale for iron
supplementation (good for mother’s health), occurrence
of gastrointestinal side-effects (black stool, constipation,
nausea, and heartburn), and how to manage such side-
effects (taking supplement with meals). In the catchment
area of these ANCCs, 611 pregnant women with fundal
height of <22 cm were identified through house-to-house
visits and invited to enroll in the antenatal care
programme. The first 4-5 women, who were enrolled in
the programme and fulfilled the inclusion criteria for
the supplementation trial (i.e. fundal height between 14
and 22 cm and no previous iron supplementation during
the current pregnancy), were invited to participate in the
next scheduled ANCC meeting. The fieldwork was
performed during May 1997-January 1998.
Of 209 participating women, 172 (82%) had
complete information on side-effects and compliance and
were included in this analysis. There was neither a
significant difference in background data
(socioeconomic status, parity) nor in allocation to
randomization groups or occurrence of side-effects
between those with and without complete side-effects
and compliance information (data not shown).
After one month of supplementation, interviews were
conducted at home, including open-ended questions on
any morbidity and gastrointestinal symptoms during the
past month. Probing regarding heartburn, nausea,
vomiting, diarrhoea, and constipation followed this.
The Medication Event Monitor System, MEMS®
(Aardex, Switzerland), was used for assessing
compliance (or adherence) to the recommended
supplementation frequency. It consists of a pill bottle
equipped with a cap, which has a counting device and a
small microprocessor embedded. Time and date were
recorded each time the bottle was opened. A special
reader was used for downloading the information from
the caps to a computer. Bottle-opening events that
occurred on the first and last days of recording were
disregarded, as they did not provide information of a
full day and included openings at the antenatal centre.
Information retrieved from week 5 to week 11 of the
supplementation was used in this analysis. Compliance
was defined as the ratio between the number of iron
tablets taken from week 5 to week 11 and the  number
of tablets prescribed for that time period.
The following three indicators of socioeconomic
status were registered based on interviews at home:
formal schooling of woman (never enrolled at school=0,
some schooling=1), household landholding (landholding
<0.5 acre=0, >=0.5 acre=1), and perceived household
economic status (deficit household economy some period
last year=0, not deficit=1). A socioeconomic score was
constructed using the accumulation of these three
indicators, ranging from 0 to 3. The score 0-1 was
labelled as ‘lower’ socioeconomic group, and the score
2-3 was labelled as ‘higher’ socioeconomic group.
Reproductive history, age, other demographic data, and
anthropometry were collected at the beginning of the
study. Concentration of haemoglobin (values not
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reported here) was measured by HemoCue® at baseline
and monthly over the course of the trial. Women with
haemoglobin <80 g/L at baseline and with single
measurement <75 g/L or two measurements 75-79 g/L
during the trial were excluded from the study and
provided appropriate additional investigation and
treatment.
Informed consents were obtained from the
participating women. The study was approved by the
Ethical Committee of the Bangladesh Medical Research
Council and by the Research Ethics Committee of the
Medical Faculty, Umeå University, Sweden.
RESULTS
In the daily- and the weekly-supplementation regimens,
62% of the women reported the occurrence of
gastrointestinal side-effects (heartburn, nausea, vomiting,
diarrhoea, or constipation) during the first month of
supplementation  (Table 1). Vomiting was reported more
frequently in the weekly-supplementation group, while
the occurrence of other suspected side-effects did not
differ between the supplementation regimens.
in the daily regimen was 59 of the recommended 77
tablets (25th percentile 30, 75th 77) and 22 of the
recommended 22 tablets in the weekly group (25th
percentile 16, 75th 27).
Presence or absence of any side-effects during week
1 to 4 did not result in a different compliance during
week 5 to 11, neither in the daily nor in weekly-
supplementation regimen (Table 2). However, the
women reporting vomiting and/or nausea had lower
compliance (62%) than those without these symptoms
(81%). Compliance did not differ between
socioeconomic strata (76% and 79% in lower and higher
strata respectively, p=0.734).
Compliance during week 5 to 11 differed between
those who had experienced vomiting and/or nausea or
not during the initial month of supplementation
(Table 3). However, only the women in the lower
socioeconomic stratum had lower compliance when
reporting side-effects. In the higher socioeconomic group,
vomiting and nausea had no influence on compliance.
Concentration of baseline haemoglobin, body mass index
Table 1. Frequency of reported symptoms (possible side-effects) after one month of antenatal iron  supplementation
in daily (n=86) and weekly (n=86) supplementation groups
Reported frequency (%) Reported frequency (%) p value
in daily supplementation in weekly supplementation
Heartburn 11.5 13.6 0.658
Nausea 14.4 17.5 0.551
Vomiting 9.6 21.4 0.019
Diarrhoea 10.6 14.6 0.389
Constipation 59.6 61.2 0.821
Any of the five 61.5 62.1 0.93
Compliance during week 5 to week 11 of the
supplementation was higher in the weekly regimen
(mean 93%) than in the daily regimen (mean 61%,
p<0.001, Fig.). In fact, the intake of tablets in the weekly
regimen ranged beyond 150% of the recommended dose
due to the intake of iron supplementation by some
women more than once per week. Measured from week
1 to week 11 of the supplementation, the median intake
at start of the study, age, or parity did not influence
compliance during week 5 to 11 (data not shown).
DISCUSSION
We have shown that compliance to supplementation of
iron in pregnancy was higher in a weekly-supplemen-
tation regimen than in a daily-supplementation regimen,
even though women in the weekly regimen did not have
Table 2. Mean compliance (ratio between observed and recommended tablet intake during week 5 to 11 of
supplementation, %) to antenatal iron supplementation in daily- and weekly-supplementation groups
with and without reported side-effects during week 1 to 4
Side-effects
No Yes p value
Daily supplements (n=86) 61.1 67.1 66.7 1
Weekly supplements (n=86) 92.7 104.5 92.9 0.898
Symptom
Regimen Total
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less but slightly more gastrointestinal side-effects. Side-
effects during the first month of supplementation did
not have any major effect on compliance, although
nausea and/or vomiting were followed by reduced
compliance in the women of a lower socioeconomic
stratum.
The design of the study included careful recall of
side-effects during the first month of supplementation,
followed by as valid measurements of compliance as
possible during the subsequent two months of
supplementation by an electronic counting device in the
pill-bottle cap (4). The women were unaware of the
microprocessor in the cap, which had an appearance of
an ordinary pill-bottle cap.
The prospectively-collected data make causal
interpretation of side-effects and subsequent compliance
Side-effects are dose-dependent (5), and current data
suggest that a dose of 30-60 mg per day may have a low
or acceptable level of gastrointestinal side-effects (6).
The weekly dose of 60 mg iron in Friday morning and
evening, used in this study, resulted in a slightly-elevated
frequency of reported side-effects compared to a daily
dose of 60 mg. This may be due to a larger daily amount
of iron ingested. The occurrence of side-effects has not
been reported to vary with type of iron compound used
(7), but with type of iron preparation. The so-called
sustained-release preparations produce fewer side-effects
but carry a higher cost (8).
Gastrointestinal side-effects are considered to be the
main reason for limited compliance (9,10), but others
do not share this view (11).  Our findings support the
view that gastrointestinal side-effects have a limited
influence on compliance, at least in the dose ranges
studied.
Table 3. Compliance (estimated mean %) to iron supplementation during week 5 to 11 of supplementation analyzed
in relation to reported vomiting or nausea during the first month of supplementation period and
socioeconomic group. Adjustment is done for supplementation regimen (daily or weekly) and parity.
Analysis of variance, F=4.6, p=0.034 (n=172)
Socioeconomic group Vomiting and/or nausea Estimated mean (%) 95% CI
Low No 81.9 73.0-90.9
Yes 47.9 30.5-65.3
High No 80.5 68.3-92.7
Yes 82.5 55.6-109.3
CI=Confidence interval
Compliance (%)
Cumulative %
0 50 100 150 200
0
25
50
75
100
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Weekly
Fig. Compliance (ratio between observed and recommended
number of tablets) to iron supplementation during week
5 to 11 is shown for daily- and weekly-supplementation
regimens (cumulative %). Median compliance in daily
group (cumulative %=50) is 65% and in weekly group
is 93%
plausible. The perceptions of side-effects
and the level of compliance to a certain
supplementation regimen may vary
between geographical settings, culture,
and socioeconomic group. Some
gastrointestinal symptoms associated with
the use of iron supplementation are also
frequently caused by pregnancy itself, e.g.
nausea, vomiting and, especially later in
pregnancy, heartburn, and constipation.
Despite probing of symptoms due to use
of supplements, the total frequency of
reported gastrointestinal symptoms may
be a mix of pregnancy-induced and iron
supplement-induced symptoms. However,
this did not confound the analysis, because
the focus was on the comparison between
supplementation regimens, and not on the
assessment of the absolute level of side-
effects.
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We did not find any variation in the frequency of side-
effects between the socioeconomic groups, but we found
a differential influence of side-effects on compliance in
the groups. The ability to understand and interpret side-
effects may counteract any negative effects on
compliance (2). This may hypothetically vary with
socioeconomic group and explain our finding.
Actual information on the occurrence of side-effects
in iron-supplementation programmes and their impact
on compliance is limited. Results of a study in Tanzania
showed that women experiencing side-effects reduced
the intake of iron supplementation by one-third, but a
large part of non-compliance remained unexplained
when the impact of side-effects had been taken into
account (12).
Emphasis has been given to the reduction of side-
effects, for example by alternative iron preparations
(12,13) or by intermittent dose regimens, e.g. weekly-
dose schedules (1). The seemingly rational thought to
reduce side-effects, thereby increasing compliance and
effectiveness of supplementation, may not be so
rewarding. Efforts to improve compliance should rather
be focused on appropriate and acceptable
supplementation regimens and motivation of recipients
of supplements.
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